NeuroAiD ™ (MLC 601) is a claimed treatment for stroke sold by Moleac Pte Ltd, a biopharmaceutical company in Singapore.
NeuroAiD ™ (MLC 601) is a claimed treatment for stroke. NeuroAiD was introduced on the international markets in 2006 by Moleac Pte Ltd, a biopharmaceutical company in Singapore.